The store will not work correctly when cookies are disabled.
(-)-(2S)-1,2-Dibenzyl-4-methyl-1,4-diazepane
ID: ALA4065245
PubChem CID: 137634288
Max Phase: Preclinical
Molecular Formula: C20H26N2
Molecular Weight: 294.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCCN(Cc2ccccc2)[C@@H](Cc2ccccc2)C1
Standard InChI: InChI=1S/C20H26N2/c1-21-13-8-14-22(16-19-11-6-3-7-12-19)20(17-21)15-18-9-4-2-5-10-18/h2-7,9-12,20H,8,13-17H2,1H3/t20-/m0/s1
Standard InChI Key: FXHVHGGUMYYBCU-FQEVSTJZSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
34.7166 -16.9242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4582 -16.5811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1968 -16.9438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5215 -17.7249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3734 -17.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0297 -18.3739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8520 -18.3798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2031 -19.1238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0212 -19.1215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4284 -19.8317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2458 -19.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6557 -19.1189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2382 -18.4087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4222 -18.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6693 -19.1073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8515 -19.1008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4502 -18.3871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6332 -18.3802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2179 -19.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6255 -19.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4411 -19.8028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8394 -16.4391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
3 5 1 0
4 6 1 0
5 7 1 0
6 7 1 0
7 8 1 6
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
6 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
3 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.44 | Molecular Weight (Monoisotopic): 294.2096 | AlogP: 3.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 6.48 | Molecular Species: BASE | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.71 | CX LogP: 3.89 | CX LogD: 1.60 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: -0.62 |
References
1. Fanter L, Müller C, Schepmann D, Bracher F, Wünsch B.. (2017) Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel σ1 receptor ligands., 25 (17): [PMID:28764962] [10.1016/j.bmc.2017.07.027] |